Brief: Paratek Pharmaceuticals Files Definitive Proxy Statement And Letter To Stockholders In Connection With Acquisition By Gurnet Point Capital And Novo Holdings
02/08/2023 23:32
Aug 2 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT
AND
LETTER TO STOCKHOLDERS IN CONNECTION WITH ACQUISITION BY GURNET
POINT CAPITAL AND NOVO HOLDINGS
Source text for Eikon: ID:nGNX3R3v4L
Further company coverage: PRTK.O
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million